BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3372313)

  • 21. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
    Bennett PF; Norman EJ
    Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal function testing in animals.
    Oliver JW
    Mod Vet Pract; 1981 Feb; 62(2):145-7. PubMed ID: 6265754
    [No Abstract]   [Full Text] [Related]  

  • 25. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
    Norman EJ; Thompson H; Mooney CT
    Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete surgical removal of a very enlarged pituitary corticotroph adenoma in a dog.
    Fracassi F; Mandrioli L; Shehdula D; Diana A; Grinwis GC; Meij BP
    J Am Anim Hosp Assoc; 2014; 50(3):192-7. PubMed ID: 24659728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiographic features of canine hyperadrenocorticism caused by autonomously functioning adrenocortical tumors: 23 cases (1978-1986).
    Penninck DG; Feldman EC; Nyland TG
    J Am Vet Med Assoc; 1988 Jun; 192(11):1604-8. PubMed ID: 3410782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes insipidus and hyperadrenocorticism associated with high plasma adrenocorticotropin concentration and a hypothalamic/pituitary mass in a dog.
    Ferguson DC; Biery DN
    J Am Vet Med Assoc; 1988 Oct; 193(7):835-9. PubMed ID: 2848001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 2: Adrenal function testing and differentiating tests.
    Bennaim M; Shiel RE; Mooney CT
    Vet J; 2019 Oct; 252():105343. PubMed ID: 31554584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic computed tomography of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism.
    van der Vlugt-Meijer RH; Meij BP; van den Ingh TS; Rijnberk A; Voorhout G
    J Vet Intern Med; 2003; 17(6):773-80. PubMed ID: 14658712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001-2003).
    Auriemma E; Barthez PY; van der Vlugt-Meijer RH; Voorhout G; Meij BP
    J Am Vet Med Assoc; 2009 Aug; 235(4):409-14. PubMed ID: 19681723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984).
    Scavelli TD; Peterson ME; Matthiesen DT
    J Am Vet Med Assoc; 1986 Nov; 189(10):1360-4. PubMed ID: 3793588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
    Dunn KJ; Herrtage ME; Dunn JK
    Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: comparison with normal dogs.
    Grooters AM; Biller DS; Theisen SK; Miyabayashi T
    J Vet Intern Med; 1996; 10(3):110-5. PubMed ID: 8743208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
    Peterson ME; Altszuler N
    Am J Vet Res; 1981 Nov; 42(11):1881-3. PubMed ID: 7199880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism.
    van der Vlugt-Meijer RH; Voorhout G; Meij BP
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):81-7. PubMed ID: 12431800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: eight cases (1976-1984).
    Sarfaty D; Carrillo JM; Peterson ME
    J Am Vet Med Assoc; 1988 Oct; 193(7):854-6. PubMed ID: 3192468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism.
    Braddock JA; Church DB; Robertson ID; Watson AD
    Aust Vet J; 2004 May; 82(5):272-7. PubMed ID: 15181926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).
    Behrend EN; Kooistra HS; Nelson R; Reusch CE; Scott-Moncrieff JC
    J Vet Intern Med; 2013; 27(6):1292-304. PubMed ID: 24112317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.